Skip to main content
. Author manuscript; available in PMC: 2009 Mar 1.
Published in final edited form as: J Immunol. 2008 Mar 1;180(5):3103–3112. doi: 10.4049/jimmunol.180.5.3103

Figure 6. Renal allograft acceptance associated with progressive IDO expression at the graft site.

Figure 6

Tissue homogenates from accepted renal allografts and isografts were evaluated by real time RT-PCR for enzyme indoleamine 2,3-dioxygenase (IDO) mRNA before (control), 30, 60–90, and 150 days after transplant. Allografts showed increased levels of IDO transcription over time that were significantly higher than controls and isografts by day 150 post-transplant (p=0.009). Each bar represents data from at least 2 mice.